We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

‘Unsurpassed Protein SEC’: OMNISEC Delivers Accurate Information with Minimal Sample

Product News   Jun 05, 2015

 
‘Unsurpassed Protein SEC’: OMNISEC Delivers Accurate Information with Minimal Sample
FURTHER INFORMATION
 
 
 

Related Product News

Developing Potent Affimer-drug Conjugates

Product News

Avacta and ADC Therapeutics are collaborating to produce Affimer-drug conjugates for patients suffering from hematological malignancies and solid tumors.

READ MORE

Industrial Scale Manufacture of Therapeutic Exosomes

Product News

BIA Separations has announced a new solution to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

READ MORE

Incorporating AI Into Drug Discovery

Product News

Optibrium™ has announced the introduction of its Augmented Chemistry™ services, which provide collaborators with novel artificial intelligence technologies for drug discovery projects.

READ MORE

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE